Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies

Abstract Background Malignant glioma cell line models are integral to pre-clinical testing of novel potential therapies. Accurate prediction of likely efficacy in the clinic requires that these models are reliable and consistent. We assessed this by examining the reporting of experimental conditions...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michael T. C. Poon, Morgan Bruce, Joanne E. Simpson, Cathal J. Hannan, Paul M. Brennan
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
GBM
Acceso en línea:https://doaj.org/article/da02e9ee3efb494ea3436c9175d4c261
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!